Susquehanna International Group’s Global Cord Blood Corporation CO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-36,000
Closed -$108K 13777
2023
Q1
$108K Sell
36,000
-600
-2% -$1.79K ﹤0.01% 11237
2022
Q4
$109K Sell
36,600
-10,600
-22% -$31.7K ﹤0.01% 10879
2022
Q3
$141K Buy
47,200
+35,700
+310% +$87.7K ﹤0.01% 11325
2022
Q2
$34K Sell
11,500
-22,800
-66% -$70.7K ﹤0.01% 12171
2022
Q1
$132K Buy
+34,300
New +$142K ﹤0.01% 11688
2021
Q3
Sell
-11,600
Closed -$62K 14151
2021
Q2
$62K Buy
+11,600
New +$60.7K ﹤0.01% 12250
2019
Q3
Sell
-11,000
Closed -$64K 11303
2019
Q2
$64K Buy
+11,000
New +$72.5K ﹤0.01% 9782
2018
Q3
Sell
-22,100
Closed -$210K 10915
2018
Q2
$210K Buy
+22,100
New +$212K ﹤0.01% 8526

Other funds holding CO

Susquehanna International Group's CO Position: Q2 2023 in Review

Susquehanna International Group sold out of Global Cord Blood Corporation (CO) in Q2 2023, closing a stake of 13,333 shares — an estimated $39.8K sold.

Susquehanna International Group first reported a position in CO in Q2 2015 and held it in 20 quarters. The position peaked at $873K in Q2 2015. 6 funds tracked by Wall St. Rank hold CO as of Q2 2023.

  • Susquehanna International Group reported no remaining Global Cord Blood Corporation position as of Q2 2023 after selling out during the quarter.
  • Susquehanna International Group sold 13,333 Global Cord Blood Corporation shares in Q2 2023, an estimated $39.8K.
  • Susquehanna International Group first reported a position in Global Cord Blood Corporation in Q2 2015 and held it in 20 quarters.
  • Susquehanna International Group's Global Cord Blood Corporation position peaked at $873K in Q2 2015.
  • 6 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.